| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
actin alpha 1, skeletal muscle | 0.540 | 0.769 | 1.1E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 1996 | 2018 | ||||||||
|
actin beta like 2 | 0.539 | 0.769 | 5.8E-16 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2020 | ||||||||
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2020 | ||||||||
|
actin gamma 2, smooth muscle | 0.505 | 0.808 | 7.1E-02 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1990 | 2020 | ||||||||
|
activin A receptor type 1 | 0.535 | 0.731 | 0.33 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
activin A receptor type 1B | 0.663 | 0.385 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
activin A receptor type 2A | 0.636 | 0.615 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
adenosine deaminase | 0.440 | 0.885 | 2.9E-12 |
|
disease | 0.150 | None | 1.000 | 5 | 0 | 2003 | 2019 | ||||||||
|
adenosine deaminase 2 | 0.545 | 0.846 | 8.1E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2018 | ||||||||
|
ADAM metallopeptidase domain 12 | 0.565 | 0.731 | 5.7E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ADAM metallopeptidase domain 33 | 0.636 | 0.423 | 2.1E-15 |
|
disease | 0.100 | None | 0.935 | 108 | 18 | 2002 | 2019 | ||||||||
|
ADAM metallopeptidase domain 3A (pseudogene) | 0.792 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
ADAM metallopeptidase domain 8 | 0.590 | 0.731 | 2.2E-14 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2007 | 2014 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 12 | 0.700 | 0.462 | 2.5E-17 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2012 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 14 | 0.792 | 0.423 | 4.8E-14 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 4 | 0.582 | 0.692 | 2.0E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 9 | 0.633 | 0.692 | 1.0E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
ADAMTS like 1 | 0.682 | 0.654 | 3.1E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
adenylate cyclase 10 | 0.663 | 0.654 | 7.4E-41 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
adenylate cyclase 2 | 0.695 | 0.308 | 1.00 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2011 | 2017 | ||||||||
|
adenylate cyclase 9 | 0.682 | 0.538 | 0.98 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2011 | 2019 | ||||||||
|
ADCYAP receptor type I | 0.561 | 0.769 | 7.2E-10 |
|
disease | 0.310 | None | 1.000 | 2 | 1 | 2011 | 2013 |